The study demonstrates the successful development of an infectious cDNA assay for human rhinovirus type 14.
Answers are grounded in this paper and cite their sources.
Enables in vitro genetic studies of rhinovirus; leaves open clinical or vaccine applications.
Development of a novel infectious cDNA assay is described for human rhinovirus type 14. A full-length cDNA clone of the human rhinovirus type 14 genome RNA was assembled and transcribed in vitro by using the SP6 transcription system. Transfection of HeLa cells with the nascent RNA resulted in the production of rhinovirus indistinguishable from the parental virus by both immunological and polyacrylamide gel analysis.
No takes yet. Share an insight, caveat, or question.
Mizutani et al. (1985) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: